Tangram Therapeutics Announces Appointment of Laura Roca-Alonso, Ph.D. as Interim Chief Executive Officer

Mar 30, 2026

Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine

Mar 5, 2026

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

Nov 26, 2025

Tangram Therapeutics to Participate in Upcoming Investor and Scientific Conferences

Oct 3, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Oct 1, 2025

e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data

Jul 10, 2025

e-therapeutics presents new data supporting ETX‑312 as a differentiated, disease-modifying near-clinic GalOmic Treatment for MASH

May 7, 2025

e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025

Feb 5, 2025

e-therapeutics Announces Business Updates and Interim Results

Oct 31, 2024

e-therapeutics to Present at Upcoming Scientific Meetings

Oct 3, 2024

Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors

Jul 16, 2024

e-therapeutics announces completion of £28.90 million fundraise

Jul 3, 2024

Pipeline update and final results for the year ended 31 January 2024

Jun 6, 2024

Lord David Prior Appointed as Chair of e‑therapeutics’ Board of Directors

May 23, 2024

Last Day of Dealings on AIM

May 8, 2024

Result of General Meeting

Apr 29, 2024

Proposed Fundraise of £28.9m and Cancellation

Apr 10, 2024

Business Update

Jan 16, 2024

Interim Results for the financial year 2023/2024

Oct 26, 2023

Final results for the year ended 31 January 2023

May 4, 2023

Filing of four new patent applications

Feb 7, 2023

Successful completion of £13.5 million fundraise

Sep 30, 2022

Interim Results for the financial year 2022/2023

Sep 30, 2022

Filing of eight patent applications on proprietary GalNAc-siRNA technology and target related innovation

Aug 1, 2022